This is an HTML version of an attachment to the Freedom of Information request 'Documents describing probabilities considered in formulating the recommendation that adults under 60 years of age strongly consider getting vaccinated with AstraZeneca'.


UNDER  
(CTH) 
1982 
ACT 
RELEASED 
BEEN  HEALTH
HAS INFORMATION 
OF 
OF 
DOCUMENT 
FREEDOM 
DEPARTMENT 
THIS 
THE  THE 
BY 

ATAGI Meeting: AstraZeneca and TTS 
7 July 2021, 1:00 – 2:00pm 
 
s 22
 
s 22
UNDER  
(CTH) 
 
ATAGI co-chair summary: 
1982 
  no change to AstraZeneca recommendations 

ACT 
  risk rates from 50 to below and over 60 years  

RELEASED 
  watching myocarditis and ITP safety signal 
  no TTS cases following dose 2 of COVID-19 Vaccine AstraZeneca 
  Include risk-benefit document in weekly updat
BEEN  e. HEALTH
 
Meeting closed at approximately 2:05pm. 
HAS INFORMATION 
OF 
OF 
DOCUMENT 
FREEDOM 
DEPARTMENT 
THIS 
THE  THE 
BY 
Document 18
Page 2 of 2
FOI 2917